<DOC>
	<DOCNO>NCT00103155</DOCNO>
	<brief_summary>RATIONALE : Radiofrequency ablation use high-frequency , electric current kill tumor cell . Ultrasound-guided radiofrequency ablation may effective treatment thyroid cancer . PURPOSE : This phase I trial study side effect radiofrequency ablation treat patient undergo surgery thyroid cancer .</brief_summary>
	<brief_title>Radiofrequency Ablation Treating Patients Who Are Undergoing Surgery Thyroid Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine frequency complication associate radiofrequency ablation ( RFA ) patient low-risk papillary thyroid cancer undergo thyroidectomy . - Determine utility RFA treatment option patient . OUTLINE : This pilot study . An electrosurgical probe place ultrasound guidance center thyroid tumor . Patients undergo radiofrequency ablation directly tumor target temperature reached* 5 minute . Patients undergo standard thyroidectomy . NOTE : *Takes approximately 15-30 minute reach target temperature . After completion study treatment , patient follow day 1 , day 14-21 , periodically deem necessary . PROJECTED ACCRUAL : A total 15-40 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Cytologically confirm papillary thyroid cancer fine needle aspiration Lowrisk disease No poorly differentiate cytology Intrathyroidal tumor Located within anterior twothirds thyroid lobe Tumor adjacent trachea neck ultrasound Tumor â‰¤ 1.5 cm neck ultrasound Requires thyroidectomy No cervical lymphadenopathy No multicentric tumor neck ultrasound No evidence lymph node metastasis PATIENT CHARACTERISTICS : Age Over 21 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>stage I papillary thyroid cancer</keyword>
</DOC>